Close Menu

NEW YORK — Saladax Biomedical said today that it has received CE marking for use of its MyCare Insite Clozapine Test by mental health professionals treating and monitoring patients with schizophrenia.

Clinicians prescribe clozapine, an antipsychotic medication, to treat severe schizophrenia symptoms in people who have not responded to other medications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.